1. Branhamella catarrhalis

   • J. Y. Riou
   • M. Guibourdenche

   Section 1: Clinical Microbiology 17 October 2012 Pages: 1 - 6

2. Serological Identification of Branhamella catarrhalis

   • Ingvar Eliasson

   Section 1: Clinical Microbiology 17 October 2012 Pages: 7 - 10

3. The Incidence and Antibiotic Susceptibility of Branhamella catarrhalis in Respiratory Infections

   • Margaret A. Colder
   • Michael J. Croughan
   • Fareed Ahmad

   Section 1: Clinical Microbiology 17 October 2012 Pages: 11 - 16

4. Sensitivity of Branhamella catarrhalis to Oral Antibiotics

   • Ingegerd Kallings

   Section 1: Clinical Microbiology 17 October 2012 Pages: 17 - 22

5. Analysis of the Relationship between Ampicillin Resistance and β-Lactamase Production in Branhamella catarrhalis

   • E. E. Stobberingh
   • H. J. van Eck
   • C. P. A. van Boven

   Section 1: Clinical Microbiology 17 October 2012 Pages: 23 - 27

6. Epidemiological and Bacteriological Findings on Branhamella catarrhalis Respiratory Infections in The Netherlands

   • B. I. Davies
   • F. P. V. Maesen

   Section 1: Clinical Microbiology 17 October 2012 Pages: 28 - 33

7. Identification and Antimicrobial Susceptibility Testing of Branhamella catarrhalis in United States Laboratories, 1983–1985

   • Ronald N. Jones
   • Herbert M. Sommers

   Section 1: Clinical Microbiology 17 October 2012 Pages: 34 - 37

8. General Discussion: Section 1

   • R. Sutherland

   Section 1: Clinical Microbiology 17 October 2012 Pages: 38 - 39

9. Classification of β-Lactamases from Branhamella catarrhalis in Relation to Penicillinases Produced by Other Bacterial Species

   • Roger Labia
   • Michel Barthelemy
   • Annie Buu Hoi-Dang Van

   Section 2: β-Lactamases of Branhamella catarrhalis 17 October 2012 Pages: 40 - 47

10. Isoelectric Focusing of β-Lactamases from Sputum and Middle Ear Isolates of Branhamella catarrhalis Recovered in the United States

    • Donald R. Nash
    • Richard J. Wallace Jr
    • Paul A. Shurin

    Section 2: β-Lactamases of Branhamella catarrhalis 17 October 2012 Pages: 48 - 54

11. Plasmid-Mediated β-Lactamase in Branhamella catarrhalis

    • Carl Kamme
    • Ingvar Eliasson
    • Martin Vang

    Section 2: β-Lactamases of Branhamella catarrhalis 17 October 2012 Pages: 55 - 63

12. Detection, Distribution and Inhibition of Branhamella catarrhalis β-Lactamases

    • A. Philippon
    • J. Y. Riou
    • F. Sotolongo

    Section 2: β-Lactamases of Branhamella catarrhalis 17 October 2012 Pages: 64 - 69

13. Inhibition of the β-Lactamases of Branhamella catarrhalis by Clavulanic Acid and Other Inhibitors

    • Tony Farmer
    • Christopher Reading

    Section 2: β-Lactamases of Branhamella catarrhalis 17 October 2012 Pages: 70 - 78

14. Inhibition of β-Lactamases in Branhamella catarrhalis

    • B. Slocombe

    Section 2: β-Lactamases of Branhamella catarrhalis 17 October 2012 Pages: 79 - 81

15. General Discussion: Section 2

    • G. N. Rolinson

    Section 2: β-Lactamases of Branhamella catarrhalis 17 October 2012 Pages: 82 - 82

16. Branhamella catarrhalis Respiratory Infections in The Netherlands

    • F. P. V. Maesen
    • B. I. Davies

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 83 - 86

17. Clinical and Bacteriological Evaluation of Branhamella catarrhalis in Respiratory Infections

    • Atsushi Saito
    • Keizo Yamaguchi
    • Kohei Hara

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 87 - 92

18. Branhamella catarrhalis as an Indirect Pathogen

    • J. K. Wardle

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 93 - 96

19. Direct and Indirect Pathogenicity of Branhamella catarrhalis

    • Itzhak Brook

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 97 - 102

20. Incidence of Branhamella catarrhalis in the Sputa of Patients with Chronic Lung Disease

    • J. Andrew Pollard
    • Richard J. Wallace Jr
    • Rebecca W. Wilson

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 103 - 108

21. Bronchopulmonary Infection due to B. catarrhalis

    • Dwight T. McLeod
    • Fareed Ahmad
    • Margaret A. Calder

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 109 - 112

22. Amoxycillin-Clavulanic Acid Combination in Bronchopulmonary Infection due to β-Lactamase-producing Branhamella catarrhalis

    • Peter E. Thornley
    • John M. Aitken
    • Nicholas J. Slevin

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 113 - 114

23. General Discussion: Section 3

    • E. A. P. Croydon

    Section 3: Therapeutic Aspects: Part 1 17 October 2012 Pages: 115 - 115

24. Upper Respiratory Tract Infections

    • Ingvar Eliasson
    • Carl Kamme

    Section 4: Therapeutic Aspects: Part 2 17 October 2012 Pages: 116 - 121

25. Therapy of Acute Otitis Media Caused by Branhamella catarrhalis

    • Paul A. Shurin
    • George F. Van Hare

    Section 4: Therapeutic Aspects: Part 2 17 October 2012 Pages: 122 - 124

26. Acute Otitis Media in Sweden

    • Kaj Lundgren
    • L. Ingvarsson

    Section 4: Therapeutic Aspects: Part 2 17 October 2012 Pages: 125 - 131

27. Otitis Media and Sinusitis in Children

    • Charles D. Bluestone

    Section 4: Therapeutic Aspects: Part 2 17 October 2012 Pages: 132 - 141

28. General Discussion: Section 4

    • O. P. W. Robinson

    Section 4: Therapeutic Aspects: Part 2 17 October 2012 Pages: 142 - 142